Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Journal of Oncology Practice
|
June 23, 2016
Innovative Strategies for Decreasing Blood Collection Wait Times for Patients in Early-Phase Cancer Clinical Trials
Bayabel Mengistu, Dina Ray, Passion Lockett, et al.
Scientific Reports
|
July 5, 2019
Functional and metabolic impairment in cigarette smoke-exposed macrophages is tied to oxidative stress
Daniel S Aridgides, Diane L Mellinger, David A Armstrong, et al.
Radiology
|
April 19, 2017
Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body Imagers
Veronica L Cox, Priya Bhosale, Gauri R Varadhachary, et al.
Parasitology Research
|
September 3, 2015
Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain
Sharon L Roy, Jane T Atkins, Rosemaria Gennuso, et al.
Biomacromolecules
|
September 25, 2012
Intravenous hemostatic nanoparticles increase survival following blunt trauma injury
Andrew J Shoffstall, Kristyn T Atkins, Rebecca E Groynom, et al.
Pediatrics
|
June 5, 2007
A national outbreak of Ralstonia mannitolilytica associated with use of a contaminated oxygen-delivery device among pediatric patients
Michael A Jhung, Rebecca H Sunenshine, Judith Noble-Wang, et al.
Oncotarget
|
June 11, 2014
Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway
Jennifer J Wheler, Stacy L Moulder, Aung Naing, et al.
The Journal of Pediatrics
|
March 10, 2001
Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection
D E Noyola, G J Demmler, C T Nelson, et al.
Cancer Chemotherapy and Pharmacology
|
January 18, 2014
Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers
Jennifer J Wheler, Filip Janku, Gerald S Falchook, et al.
Oncotarget
|
May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms
Jennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Journal of Oncology Practice
|
June 23, 2016
Innovative Strategies for Decreasing Blood Collection Wait Times for Patients in Early-Phase Cancer Clinical Trials
Bayabel Mengistu, Dina Ray, Passion Lockett, et al.
Scientific Reports
|
July 5, 2019
Functional and metabolic impairment in cigarette smoke-exposed macrophages is tied to oxidative stress
Daniel S Aridgides, Diane L Mellinger, David A Armstrong, et al.
Radiology
|
April 19, 2017
Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body Imagers
Veronica L Cox, Priya Bhosale, Gauri R Varadhachary, et al.
Parasitology Research
|
September 3, 2015
Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain
Sharon L Roy, Jane T Atkins, Rosemaria Gennuso, et al.
Biomacromolecules
|
September 25, 2012
Intravenous hemostatic nanoparticles increase survival following blunt trauma injury
Andrew J Shoffstall, Kristyn T Atkins, Rebecca E Groynom, et al.
Pediatrics
|
June 5, 2007
A national outbreak of Ralstonia mannitolilytica associated with use of a contaminated oxygen-delivery device among pediatric patients
Michael A Jhung, Rebecca H Sunenshine, Judith Noble-Wang, et al.
Oncotarget
|
June 11, 2014
Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway
Jennifer J Wheler, Stacy L Moulder, Aung Naing, et al.
The Journal of Pediatrics
|
March 10, 2001
Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection
D E Noyola, G J Demmler, C T Nelson, et al.
Cancer Chemotherapy and Pharmacology
|
January 18, 2014
Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers
Jennifer J Wheler, Filip Janku, Gerald S Falchook, et al.
Oncotarget
|
May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms
Jennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Page
of 9